764 Results of Andante, a Randomized Clinical Study With an Anti-IL6 Antibody (PF-04236921) in Subjects With Crohn's Disease Who Are Anti-TNF Inadequate RespondersSilvio Danese, Stefan Schreiber, Gerhard Rogler et al.|Gastroenterology|2016Cited by 7
Results of ANDANTE, a randomised clinical study with an anti-IL6 antibody (PF-04236921) in subjects with Crohn's disease who are antitumour necrosis factor inadequate respondersSilvio Danese, Stefan Schreiber, Séverine Vermeire et al.|Unknown|2016Cited by 7